DK1315496T3 - Behandling af inflammatoriske lidelser - Google Patents

Behandling af inflammatoriske lidelser

Info

Publication number
DK1315496T3
DK1315496T3 DK01963202T DK01963202T DK1315496T3 DK 1315496 T3 DK1315496 T3 DK 1315496T3 DK 01963202 T DK01963202 T DK 01963202T DK 01963202 T DK01963202 T DK 01963202T DK 1315496 T3 DK1315496 T3 DK 1315496T3
Authority
DK
Denmark
Prior art keywords
treatment
inflammatory disorders
inflammatory
mefloquine
administration
Prior art date
Application number
DK01963202T
Other languages
English (en)
Inventor
Benjamin Mark Skead
Robin Mark Bannister
Alan Rothaul
Original Assignee
Arakis Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Arakis Ltd filed Critical Arakis Ltd
Application granted granted Critical
Publication of DK1315496T3 publication Critical patent/DK1315496T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/49Cinchonan derivatives, e.g. quinine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/08Bronchodilators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/06Antipsoriatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pain & Pain Management (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
DK01963202T 2000-09-05 2001-08-31 Behandling af inflammatoriske lidelser DK1315496T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0021776.0A GB0021776D0 (en) 2000-09-05 2000-09-05 The treatment of inflammatory disorders

Publications (1)

Publication Number Publication Date
DK1315496T3 true DK1315496T3 (da) 2005-11-14

Family

ID=9898880

Family Applications (1)

Application Number Title Priority Date Filing Date
DK01963202T DK1315496T3 (da) 2000-09-05 2001-08-31 Behandling af inflammatoriske lidelser

Country Status (22)

Country Link
US (2) US7034028B2 (da)
EP (1) EP1315496B1 (da)
JP (1) JP2004508323A (da)
CN (1) CN1309388C (da)
AT (1) ATE302008T1 (da)
AU (2) AU2001284234B2 (da)
BR (1) BR0113646A (da)
CA (1) CA2419601A1 (da)
DE (1) DE60112768T2 (da)
DK (1) DK1315496T3 (da)
ES (1) ES2245372T3 (da)
GB (1) GB0021776D0 (da)
HK (1) HK1054324A1 (da)
HU (1) HUP0300934A2 (da)
IL (1) IL154419A0 (da)
MX (1) MXPA03001920A (da)
NO (1) NO323227B1 (da)
NZ (1) NZ524099A (da)
PL (1) PL364030A1 (da)
PT (1) PT1315496E (da)
WO (1) WO2002019994A2 (da)
ZA (1) ZA200301139B (da)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0021776D0 (en) * 2000-09-05 2000-10-18 Arakis Ltd The treatment of inflammatory disorders
GB0406014D0 (en) * 2004-03-17 2004-04-21 Arakis Ltd Pharmaceutical composition and use
WO2006108666A1 (en) * 2005-04-13 2006-10-19 Proteosys Ag Mefloquine, nelfinavir and saquinavir as novel agents for neurodegenerative and (neuro-) inflammatory diseases
JP2010513469A (ja) * 2006-12-20 2010-04-30 メドウェル ラボラトリーズ リミテッド ポリ不飽和脂肪酸とアミンの新規なコンジュゲート、およびその治療的使用
EP2590641A2 (en) * 2010-07-07 2013-05-15 Polymedix, Inc. Methods of immune modulation
CN113578299B (zh) * 2020-04-30 2023-11-10 中国石油化工股份有限公司 一种硅铝锆复合氧化物、催化裂化催化剂及其制备方法和应用
CN114452289B (zh) * 2020-12-31 2023-06-09 兰州大学 喹啉类衍生物在制备预防和/或治疗胃肠道疾病药物中的应用
CN114796216A (zh) * 2022-01-04 2022-07-29 南京医科大学 甲氟喹在防治全身代谢性炎症疾病中的应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU633499B2 (en) * 1988-06-30 1993-02-04 Michael H. Davis Method of inhibiting the activity of human immunodeficiency virus (hiv) in vivo
CZ285937B6 (cs) * 1992-01-16 1999-12-15 Hoechst Aktiengesellschaft Arylcykloalkylové deriváty, způsob přípravy těchto derivátů a jejich použití
WO1995024398A1 (en) * 1994-03-09 1995-09-14 Pfizer Inc. Isoxazoline compounds as inhibitors of tnf release
JP4380800B2 (ja) 1997-03-07 2009-12-09 バーナリス リサーチ リミテッド マラリアの処置のための(+)メフロキンの使用
WO1999026627A1 (en) * 1997-11-26 1999-06-03 Cerebrus Limited (-)-mefloquine to block purinergic receptors and to treat movement or neurodegenerative disorders
EP1175216A2 (en) * 1999-04-30 2002-01-30 APT Pharmaceutical, L.L.C. Antimalarian agents for the treatment of asthma
GB0021776D0 (en) * 2000-09-05 2000-10-18 Arakis Ltd The treatment of inflammatory disorders

Also Published As

Publication number Publication date
PL364030A1 (en) 2004-12-13
AU8423401A (en) 2002-03-22
NZ524099A (en) 2004-04-30
GB0021776D0 (en) 2000-10-18
HUP0300934A2 (hu) 2003-11-28
ATE302008T1 (de) 2005-09-15
WO2002019994A2 (en) 2002-03-14
EP1315496B1 (en) 2005-08-17
EP1315496A2 (en) 2003-06-04
CN1309388C (zh) 2007-04-11
CA2419601A1 (en) 2002-03-14
DE60112768T2 (de) 2006-02-02
MXPA03001920A (es) 2004-02-12
WO2002019994A3 (en) 2002-05-16
NO20030985L (no) 2003-03-03
JP2004508323A (ja) 2004-03-18
NO323227B1 (no) 2007-02-05
NO20030985D0 (no) 2003-03-03
US20040029916A1 (en) 2004-02-12
IL154419A0 (en) 2003-09-17
US20060074106A1 (en) 2006-04-06
ZA200301139B (en) 2004-03-29
HK1054324A1 (en) 2003-11-28
DE60112768D1 (de) 2005-09-22
CN1452488A (zh) 2003-10-29
BR0113646A (pt) 2004-01-06
ES2245372T3 (es) 2006-01-01
AU2001284234B2 (en) 2004-11-04
US7034028B2 (en) 2006-04-25
PT1315496E (pt) 2005-11-30

Similar Documents

Publication Publication Date Title
DK1459750T3 (da) (S,S)-rebexetin til behandling af fibromyalgi og andre somatoforme lidelser
DK1660458T3 (da) 2, 4-pyrimidindiaminer egnede i behandling af neoplastiske sygdomme, in-flammatoriske lidelser og lidelser i immunsystemet.
NL1017508A1 (nl) Formatiebehandelingswerkwijze die vervormbare deeltjes gebruikt.
DK1047428T3 (da) Anvendelse af morpholinol til behandlingen af seksualforstyrrelser
ID30276A (id) Metode untuk mengobati gangguan-gangguan seksual
DK1315496T3 (da) Behandling af inflammatoriske lidelser
NL1021504A1 (nl) Waterstofbehandelingsproces.
DK1220852T3 (da) Substituerede diazepaner
BR0112264B1 (pt) dispositivo de tratamento de sangue.
IS7868A (is) Notkun á kortkólíberín-úrókortín kerfi í meðferð á bólguvaldandi sjúkdómum.
ATE306977T1 (de) Schaukel für behinderte
BR0115882A (pt) Emprego de compostos de 1-fenil-3-dimetilaminopropano no tratamento da incontinência urinária
TR200200278T2 (tr) Kalsilitik bileşimler
DK1244438T3 (da) Anvendelse af beta-adrenoceptorantagonister til fremstilling af et medikament til behandling af sygdomme i den ydre nethinde
NO20005548D0 (no) Mykobakterieinhibitorer
PT1273556E (pt) Estacao de tratamento simbiotico de aguas residuais.
EP1409041A4 (en) HEMOFILTRATION SYSTEMS, METHODS AND DEVICES FOR THE TREATMENT OF DISEASES RELATED TO INFLAMMATION MEDIATORS
ATE345818T1 (de) S-methyl-dihydro-ziprasidone zur behandlung von psychiatrischen störungen.
DK1459748T3 (da) (S,S)-reboxetin til behandling af perifer neuropati
IT1319665B1 (it) Addotti di corticosteroidi con polimeri polisaccaridici naturali.
UA40336A (uk) Спосіб хірургічного лікування екстрапірамідних гіперкінезів у хворих із церебросудинною патологією
DE60111519D1 (de) Chemische modifizierung von harn von säugern
ES1043843Y (es) Generador de ruido blanco para la terapia del tinnitus.
ES1047369Y (es) Bañera perfeccionada para personas con discapacidades fisicas.
FR2795307B1 (fr) Le pese-nerfs, appareillage orthopedique